AR038198A1 - Usos farmaceuticos de un inhibidor de cox-2 - Google Patents
Usos farmaceuticos de un inhibidor de cox-2Info
- Publication number
- AR038198A1 AR038198A1 ARP030100167A ARP030100167A AR038198A1 AR 038198 A1 AR038198 A1 AR 038198A1 AR P030100167 A ARP030100167 A AR P030100167A AR P030100167 A ARP030100167 A AR P030100167A AR 038198 A1 AR038198 A1 AR 038198A1
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- pharmaceutically acceptable
- cox
- inhibitor
- pharmaceutical uses
- Prior art date
Links
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 methoxy, ethoxy Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Reivindicación 1: El uso de un compuesto de la fórmula (1), en donde: R es metilo o etilo, R1 es Cl o F, R2 es H o F; R3 es H, F, Cl, metilo, etilo, metoxilo, etoxilo o hidroxilo; R4 es H o F; y R5 es Cl, F, trifluorometilo o metilo; o una sal o éster de profármaco farmacéuticamente aceptable del mismo, en la preparación de un medicamento para utilizarse en el tratamiento de un desorden ocular mediado por angiogénesis. Reivindicación 4: El uso de acuerdo con la reivindicación 1, o el método de acuerdo con la reivindicación 2, o el paquete de acuerdo con la reivindicación 3, en donde el compuesto de la fórmula (1) es ácido 5-metil-2-(2'-cloro-6'-fluoroanilino)-fenilacético o una sal farmacéuticamente aceptable del mismo, o un éster de profármaco farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201520.4A GB0201520D0 (en) | 2002-01-23 | 2002-01-23 | Pharmaceutical uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038198A1 true AR038198A1 (es) | 2005-01-05 |
Family
ID=9929598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100167A AR038198A1 (es) | 2002-01-23 | 2003-01-21 | Usos farmaceuticos de un inhibidor de cox-2 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20050043410A1 (es) |
| EP (1) | EP1503746B1 (es) |
| JP (1) | JP2005515241A (es) |
| CN (1) | CN1283240C (es) |
| AR (1) | AR038198A1 (es) |
| AT (1) | ATE375154T1 (es) |
| BR (1) | BR0307013A (es) |
| CA (1) | CA2468811C (es) |
| CY (1) | CY1106994T1 (es) |
| DE (1) | DE60316792T2 (es) |
| DK (1) | DK1503746T3 (es) |
| ES (1) | ES2291641T3 (es) |
| GB (1) | GB0201520D0 (es) |
| MY (1) | MY145266A (es) |
| PT (1) | PT1503746E (es) |
| TW (1) | TWI280878B (es) |
| WO (1) | WO2003061645A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| WO2005049014A1 (en) * | 2003-11-18 | 2005-06-02 | Pharmacia Corporation | Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders |
| CN102149728B (zh) * | 2008-09-10 | 2014-10-15 | 霍夫曼-拉罗奇有限公司 | 抑制眼部血管生成的方法 |
| WO2010132634A1 (en) * | 2009-05-15 | 2010-11-18 | Glaxosmithkline Llc | Using thermal imaging for control of a manufacturing process |
| WO2019070917A1 (en) * | 2017-10-03 | 2019-04-11 | The Schepens Eye Research Institute, Inc. | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME |
| CN114652826B (zh) * | 2022-01-24 | 2022-10-14 | 景泽生物医药(合肥)有限公司 | 抗egfr抗体的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652762A (en) * | 1970-04-14 | 1972-03-28 | Ciba Geigy Corp | Pharmaceutical compositions and methods employing substituted derivatives of 2-anilinophenylacetic acids and esters |
| CO4960662A1 (es) * | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| KR100645866B1 (ko) * | 1999-12-08 | 2006-11-15 | 파마시아 코포레이션 | 발데콕시브 조성물 |
| AR030630A1 (es) * | 2000-09-11 | 2003-08-27 | Novartis Ag | Composiciones farmaceuticas |
| US20030114527A1 (en) * | 2001-08-31 | 2003-06-19 | Karnachi Anees Abdulquadar | Pharmaceutical composition |
| CA2472585A1 (en) * | 2002-01-07 | 2003-07-17 | Pharmacia Corporation | Drug mixture with enhanced dissolution rate |
-
2002
- 2002-01-23 GB GBGB0201520.4A patent/GB0201520D0/en not_active Ceased
-
2003
- 2003-01-20 TW TW092101106A patent/TWI280878B/zh not_active IP Right Cessation
- 2003-01-21 AR ARP030100167A patent/AR038198A1/es unknown
- 2003-01-22 CN CNB038025833A patent/CN1283240C/zh not_active Expired - Fee Related
- 2003-01-22 MY MYPI20030212A patent/MY145266A/en unknown
- 2003-01-22 PT PT03731699T patent/PT1503746E/pt unknown
- 2003-01-22 EP EP03731699A patent/EP1503746B1/en not_active Expired - Lifetime
- 2003-01-22 CA CA2468811A patent/CA2468811C/en not_active Expired - Fee Related
- 2003-01-22 WO PCT/EP2003/000612 patent/WO2003061645A1/en not_active Ceased
- 2003-01-22 DE DE60316792T patent/DE60316792T2/de not_active Expired - Lifetime
- 2003-01-22 ES ES03731699T patent/ES2291641T3/es not_active Expired - Lifetime
- 2003-01-22 US US10/502,180 patent/US20050043410A1/en not_active Abandoned
- 2003-01-22 AT AT03731699T patent/ATE375154T1/de active
- 2003-01-22 BR BR0307013-1A patent/BR0307013A/pt not_active Application Discontinuation
- 2003-01-22 DK DK03731699T patent/DK1503746T3/da active
- 2003-01-22 JP JP2003561590A patent/JP2005515241A/ja active Pending
-
2007
- 2007-11-08 CY CY20071101445T patent/CY1106994T1/el unknown
-
2009
- 2009-06-10 US US12/481,609 patent/US20090247638A1/en not_active Abandoned
-
2012
- 2012-08-24 US US13/593,959 patent/US20120322874A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200302081A (en) | 2003-08-01 |
| BR0307013A (pt) | 2004-11-03 |
| CA2468811A1 (en) | 2003-07-31 |
| EP1503746B1 (en) | 2007-10-10 |
| CN1283240C (zh) | 2006-11-08 |
| PT1503746E (pt) | 2008-01-10 |
| MY145266A (en) | 2012-01-13 |
| JP2005515241A (ja) | 2005-05-26 |
| CN1620288A (zh) | 2005-05-25 |
| US20090247638A1 (en) | 2009-10-01 |
| DE60316792D1 (de) | 2007-11-22 |
| WO2003061645A1 (en) | 2003-07-31 |
| CY1106994T1 (el) | 2012-09-26 |
| CA2468811C (en) | 2011-08-09 |
| DK1503746T3 (da) | 2008-02-04 |
| US20120322874A1 (en) | 2012-12-20 |
| EP1503746A1 (en) | 2005-02-09 |
| ES2291641T3 (es) | 2008-03-01 |
| GB0201520D0 (en) | 2002-03-13 |
| TWI280878B (en) | 2007-05-11 |
| ATE375154T1 (de) | 2007-10-15 |
| US20050043410A1 (en) | 2005-02-24 |
| DE60316792T2 (de) | 2008-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0311337A (pt) | Uso oftalmológico de roflumilast para o tratamento de doenças do olho | |
| AR061846A1 (es) | Compuestos heteroaromaticos de azol inhibidores selectivos de la pde10a, composiciones farmaceuticas que los contienen y usos para tratar trastornos asociados al cns. | |
| AR082825A2 (es) | Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios | |
| BR0115382A (pt) | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica | |
| BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
| SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| AR087241A2 (es) | Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| AR039419A1 (es) | Compuesto de benzopiran-4-ona, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento | |
| AR034556A1 (es) | Un derivado de fenilalanina, una composicion farmaceutica que comprende al derivado de fenilalanina, el uso del derivado y proceso para preparar dicho derivado | |
| MA30821B1 (fr) | Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
| ECSP055745A (es) | Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona | |
| AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
| CO5560554A2 (es) | Composicion farmaceutica que comprende lumiracoxib | |
| AR030630A1 (es) | Composiciones farmaceuticas | |
| AR035750A1 (es) | Uso de n- (piridinilamino) indoles para la preparacion de medicamentos para el tratamiento de enfermedades o trastornos desmielinizantes | |
| AR038198A1 (es) | Usos farmaceuticos de un inhibidor de cox-2 | |
| PL360492A1 (en) | Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates | |
| ES2179523T3 (es) | Metodo para aumentar la biodisponibilidad de la fexofenadina y sus derivados. | |
| AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
| AR041069A1 (es) | Composicion de tolterodina liquida oral | |
| ES2190985T3 (es) | Tratamiento de migraña por administracion de acido alfa-lipoico o de derivados del mismo. | |
| EA200800071A1 (ru) | Производные бензофуранила как ингибиторы 5-нт6-рецептора | |
| RU2003104017A (ru) | Ингибиторы тромбина, содержащие аминоизохинолиновую группу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |